NCT00657969

Brief Summary

The main purpose of this study is to look for genetic and environmental risk factors of cervical artery dissections, a major cause of ischemic stroke in young adults, in a large multicenter case-control trial

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4,169

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2005

Longer than P75 for all trials

Geographic Reach
9 countries

24 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2005

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

April 8, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 14, 2008

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
Last Updated

October 21, 2009

Status Verified

October 1, 2009

Enrollment Period

3.5 years

First QC Date

April 8, 2008

Last Update Submit

October 20, 2009

Conditions

Keywords

Polymorphism, geneticRisk factorsCarotid Artery, Internal, DissectionVertebral Artery DissectionGenetic predispositionOutcomeTherapy

Outcome Measures

Primary Outcomes (1)

  • association of genetic polymorphisms with cervical artery dissections

    2009

Secondary Outcomes (2)

  • association of environmental risk factors with cervical artery dissections

    2009

  • gene-environment interactions

    2009

Study Arms (3)

1

CAD-group (Cervical Artery Dissection - group): consecutive patients with cervical artery dissection, with or without associated cerebral ischemia, hospitalized in one of the participating neurological centers; standardized inclusion and exclusion criteria apply

2

IS-group (Ischemic Stroke - Group): patients selected among consecutive patients hospitalized for an ischemic stroke without CAD, in the same centers as patients from group1, frequency-matched on age and gender with group1; standardized inclusion and exclusion criteria apply

3

HC-group (Healthy Control - Group): DNA of healthy individuals from existing DNA-databases will be used as controls for the Belgian, French, German and Swiss centers; the other centers are recruiting their own age- and sex-matched healthy controls; individuals from the 3 groups (CAD, IS and HC) are strictly matched on geographical origin in order to avoid stratification bias

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

groups 1 and 2: hospital-based, neurology departments group 3: community samples

You may qualify if:

  • Typical radiological aspect of dissection\* in a cervical artery (carotid and/or vertebral);\* Mural hematoma, pseudoaneurysm, long tapering stenosis, intimal flap, double lumen, or occlusion \> 2 cm above the carotid bifurcation revealing a pseudo aneurysm or a long tapering stenosis after recanalisation
  • Written informed consent

You may not qualify if:

  • Purely intracranial dissection
  • Dissection occurring after an endovascular procedure
  • Known mendelian genetic disorder that can explain the dissection (e.g. vascular Ehlers-Danlos syndrome)
  • GROUP2:
  • Recent ischemic stroke
  • No signs of CAD on extracranial duplex sonography and angiography (digital subtraction or magnetic resonance or CT), performed \< 7 days after the stroke
  • Written informed consent
  • Possible cerebral ischemia but normal cerebral imaging
  • CAD cannot be ruled out (e.g.persistent arterial occlusion without mural hematoma)
  • Endovascular or surgical procedure on the coronary, cervical or cerebral arteries during the 48 hours preceding the cerebral infarction
  • Cardiopathies with a very high embolic risk (Mechanical prosthetic valves, mitral stenosis with atrial fibrillation, intracardiac tumor, infectious endocarditis, myocardial infarction\<4 months)
  • Arterial vasospasm following a subarachnoid haemorrhage
  • Auto-immune disease possibly responsible for the cerebral infarction
  • Known monogenic disease responsible for the cerebral infarction
  • GROUP3:
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (24)

Sanatorio Allende

Córdoba, 5000, Argentina

Location

Department of Neurology, University Hospital of Brussels (ULB)

Brussels, 1070, Belgium

Location

Department of Neurology, University Hospital of Leuven

Leuven, 3000, Belgium

Location

Department of Neurology, Helsinki University Central Hospital

Helsinki, 00290, Finland

Location

Department of Neurology, University Hospital of Amiens

Amiens, 80000, France

Location

Department of Neurology, University Hospital of Besançon

Besançon, 25000, France

Location

Department of Neurology, University Hospital of Dijon

Dijon, 21000, France

Location

Department of Neurology, University Hospital of Lille

Lille, 59000, France

Location

Inserm U744 Institut Pasteur de Lille

Lille, 59000, France

Location

Department of Neurology, University Hospital Pitié-Salpêtrière

Paris, 75013, France

Location

Department of Neurology, University Hospital Sainte-Anne

Paris, 75015, France

Location

Rehabilitation Center, Schmieder-Klinik

Heidelberg, 62120, Germany

Location

Department of Neurology, University Hospital of Heidelberg

Heidelberg, 69120, Germany

Location

Department of Neurology, Hospital of Ludwigshafen

Ludwigshafen, 67063, Germany

Location

Department of Neurology, University Hospital of Munich

Munich, 81377, Germany

Location

Department of Neurology, University Hospital of Brescia

Brescia, 25100, Italy

Location

Department of Neurology, Ospedale Maggiore Policlinico di Milano

Milan, 20100, Italy

Location

Ospedale Milano San Raffaele

Milan, 20132, Italy

Location

Department of Neurology, University Hospital Milano-Bicocca

Monza, 20052, Italy

Location

Department of Neurology, University Hospital of Perugia

Perugia, 06081, Italy

Location

Rehabilitation Center, IRCCS Santa Lucia, Roma

Rome, 00100, Italy

Location

Department of Neurology, University Hospital of Basel

Basel, 4031, Switzerland

Location

Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University

Istanbul, Turkey (Türkiye)

Location

Department of Neuroscience, St George's University Hospital of London

London, SW170RE, United Kingdom

Location

Related Publications (2)

  • Engelter ST, Brandt T, Debette S, Caso V, Lichy C, Pezzini A, Abboud S, Bersano A, Dittrich R, Grond-Ginsbach C, Hausser I, Kloss M, Grau AJ, Tatlisumak T, Leys D, Lyrer PA; Cervical Artery Dissection in Ischemic Stroke Patients (CADISP) Study Group. Antiplatelets versus anticoagulation in cervical artery dissection. Stroke. 2007 Sep;38(9):2605-11. doi: 10.1161/STROKEAHA.107.489666. Epub 2007 Jul 26.

    PMID: 17656656BACKGROUND
  • Debette S, Metso TM, Pezzini A, Engelter ST, Leys D, Lyrer P, Metso AJ, Brandt T, Kloss M, Lichy C, Hausser I, Touze E, Markus HS, Abboud S, Caso V, Bersano A, Grau A, Altintas A, Amouyel P, Tatlisumak T, Dallongeville J, Grond-Ginsbach C; CADISP-group. CADISP-genetics: an International project searching for genetic risk factors of cervical artery dissections. Int J Stroke. 2009 Jun;4(3):224-30. doi: 10.1111/j.1747-4949.2009.00281.x.

    PMID: 19659826BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

DNA, plasma, serum

MeSH Terms

Conditions

StrokeBrain InfarctionCarotid Artery, Internal, DissectionVertebral Artery DissectionGenetic Predisposition to Disease

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBrain IschemiaInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisCarotid Artery InjuriesCarotid Artery DiseasesCerebrovascular TraumaTrauma, Nervous SystemDissection, Blood VesselAneurysmWounds and InjuriesDisease SusceptibilityDisease Attributes

Study Officials

  • Stéphanie Debette, MD, PhD

    Department of Neurology (EA2691), University Hospital of Lille; Inserm, U744, Pasteur Institute, Lille, France

    STUDY DIRECTOR
  • Caspar Grond-Ginsbach, PhD

    Department of Neurology, University Hospital of Heidelberg, Germany

    STUDY CHAIR
  • Didier Leys, MD PhD

    Department of Neurology (EA2691), University Hospital of Lille, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Sponsor Type
NETWORK

Study Record Dates

First Submitted

April 8, 2008

First Posted

April 14, 2008

Study Start

July 1, 2005

Primary Completion

January 1, 2009

Study Completion

September 1, 2009

Last Updated

October 21, 2009

Record last verified: 2009-10

Locations